卡泊芬净治疗肺黄曲霉病失败1例
Failure of caspofungin in one case of patient with invasive pulmonary aspergillosis
摘要
随着肿瘤化疗强度的不断增加、免疫抑制剂大量使用以及艾滋病患者的增多,曲霉感染明显上升。侵袭性曲霉感染的首选药物为伏立康唑,棘白菌素类常被作为二线药物使用。三唑类耐药的曲霉感染报道很多,但原发或继发性棘白菌素类耐药的曲霉感染报道极少。我们收治1例卡泊芬净治疗无效的侵袭性肺曲霉感染患者,现报道如下。
出处
《中国感染与化疗杂志》
CAS
北大核心
2012年第1期65-66,共2页
Chinese Journal of Infection and Chemotherapy
参考文献7
-
1Madureira A, Bergeron A, Lacroix C, et al. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem ce transplant recipients treated with caspofungin[J]. Int J Antimicrob Agents, 2007,30(6) :551-554.
-
2Eschertzhuber S, Velik Salchner C, Hoermann C, et al. Caspofungin-resistant Aspergillus flavus after heart transplantation and mechanical circulatory support: a case report[J]. Transpl Infect Dis, 2008,10(3) :190-192.
-
3Arendrup MC, Perkhofer S, Howard SJ, et al. Establishing in vitro in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins[J]. Antimicrob Agents, Chemother, 201)8, 52(10): 3504-3511.
-
4Howard SJ, Arendrup MC. Acquired antifungal drug resist ance in Aspergillus fumigatus: epidemiology and detection[J]. Med Mycol, 2011,49 Suppl 1 :S90-95.
-
5Romano J, Nimrod G, Ben Tal N, et al. Disruption of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence[J]. Microbiology, 2006,152(Pt 7) : 1919-1928.
-
6Gardiner RE, Souteropoulos P, Park S, et al. Characteriza tion of Aspergillus fumigatus mutants with reduced susceptibiity to caspofungin[J]. Med Mycol, 2005,43 Suppl 1:S299-305.
-
7Pavie J, Lacroix C, Hermoso DG, et al. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis[J]. J Clin Microbiol, 2005,43 (9) : 4902-4904.
-
1张玉坤,陈军,詹英.重症患者合并真菌感染的治疗[J].中国医药导报,2011,8(18):55-56. 被引量:3
-
2封秀琴,黄科儿,朱祎容.侵袭性肺部和中枢神经系统曲霉感染一例[J].中华急诊医学杂志,2012,21(6):657-659. 被引量:1
-
3李若瑜,陈剑.抗真菌药物耐药研究现状[J].中国处方药,2002,1(9):17-20. 被引量:2
-
4徐英春,谢秀丽,王澎,张悦贤,原英,张小江,朱任媛,刘娟,王辉,陈民钧.Etest法测定伊曲康唑对曲霉和酵母菌的体外抗菌活性[J].中国新药杂志,2004,13(2):163-165. 被引量:2
-
5Singh N,Limaye AP,Forrest G,邓妍.联合应用伏立康唑和卡泊芬净可有效治疗侵袭性曲霉感染[J].中国处方药,2006,5(3):52-52. 被引量:28
-
6郑方算.侵袭性曲霉感染的药物治疗进展[J].国外医药(抗生素分册),2001,22(5):204-206. 被引量:2
-
7郑行春,胡永芳.伏立康唑预防血液病患者侵袭性真菌感染的疗效与安全性[J].中国临床药理学杂志,2012,28(10):782-784. 被引量:5
-
8姜铧,万楚成,章正华,夏云金,张霞,胡明均,龙志国.急性白血病化疗后并发深部真菌感染临床分析[J].临床荟萃,2006,21(15):1118-1120. 被引量:4
-
9栾霞,张星霖,杨庆辉.左卡尼汀对阿霉素心脏毒性的保护作用[J].中国慢性病预防与控制,2006,14(4):268-269. 被引量:5
-
10虞瑞尧.抗真菌药的近况与开发[J].中国新药杂志,1999,8(4):229-232. 被引量:12